CARLSMED INC (CARL) Stock Price, Forecast & Analysis
USA - NASDAQ:CARL - US14280C1053 - Common Stock
CARL Key Statistics, Chart & Performance
The current stock price of CARL is 13.11 USD. In the past month the price decreased by -3.25%.
CARL Latest News, Press Relases and Analysis
CARL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.17 | 227.29B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.82 | 196.99B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.81 | 152.16B | ||
| SYK | STRYKER CORP | 27.5 | 138.48B | ||
| BDX | BECTON DICKINSON AND CO | 13.39 | 55.33B | ||
| IDXX | IDEXX LABORATORIES INC | 54.71 | 55.19B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.58 | 50.67B | ||
| RMD | RESMED INC | 24.69 | 35.68B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.40B | ||
| PODD | INSULET CORP | 72.8 | 23.42B | ||
| DXCM | DEXCOM INC | 31.22 | 22.77B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.11 | 17.81B |
Related stock screener links
About CARL
Company Profile
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 100 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Company Info
CARLSMED INC
1800 Aston Ave., Suite 100
Carlsbad CALIFORNIA US
Employees: 100
Phone: 17607661923
CARLSMED INC / CARL FAQ
What does CARLSMED INC do?
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 100 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
What is the current price of CARL stock?
The current stock price of CARL is 13.11 USD. The price increased by 3.07% in the last trading session.
Does CARLSMED INC pay dividends?
CARL does not pay a dividend.
How is the ChartMill rating for CARLSMED INC?
CARL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for CARL stock?
11 analysts have analysed CARL and the average price target is 18.77 USD. This implies a price increase of 43.16% is expected in the next year compared to the current price of 13.11.
Can you provide the PE ratio for CARL stock?
CARLSMED INC (CARL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.87).
CARL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CARL.
CARL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CARL. While CARL seems to be doing ok healthwise, there are quite some concerns on its profitability.
CARL Financial Highlights
Over the last trailing twelve months CARL reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS decreased by -31.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.29% | ||
| ROE | -193.71% | ||
| Debt/Equity | 0.6 |
CARL Forecast & Estimates
11 analysts have analysed CARL and the average price target is 18.77 USD. This implies a price increase of 43.16% is expected in the next year compared to the current price of 13.11.
For the next year, analysts expect an EPS growth of -45.31% and a revenue growth -12.4% for CARL